Source:http://linkedlifedata.com/resource/pubmed/id/20832114
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-11-18
|
pubmed:abstractText |
Neuropeptide Y (NPY) is an important hormone in appetite regulation. Although the contribution of NPY to metabolic disease has been previously demonstrated, there are only a few reports addressing NPY plasma levels under distinct diabetic conditions. In this study we evaluated NPY plasma levels in diabetes mellitus type 2 (DM2) patients with (n=34) and without (n=34) diabetic polyneuropathy (PNP) and compared these with age and gender matched healthy controls (n=34). We also analyzed NPY plasma levels in gestational diabetes mellitus (GDM) patients with age and pregnancy-week matched controls with normal glucose tolerance (NGT). NPY concentration was determined using a commercially available radioimmunoassay kit. In addition, metabolic parameters of DM2 and GDM patients were recorded. One-way ANOVA tests with appropriate post hoc corrections showed elevated levels of NPY in DM2 patients with and without PNP when compared with those of healthy controls (122.32±40.86 and 117.33±29.92 vs. 84.65±52.17 pmol/L; p<0.001, p<0.005, respectively). No significant difference was observed between diabetic patients with and without PNP. The NPY levels were similar in the GDM group and in pregnant women with NGT (74.87±14.36 vs. 84.82±51.13 pmol/L, respectively). Notably, the NPY concentration correlated positively with insulin levels in DM2 patients (R=0.35, p<0.01). Our data suggest a potential involvement of circulating NPY in DM2 pathology.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1532-2785
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
485-9
|
pubmed:meshHeading |
pubmed-meshheading:20832114-Adult,
pubmed-meshheading:20832114-Aged,
pubmed-meshheading:20832114-Body Mass Index,
pubmed-meshheading:20832114-Diabetes, Gestational,
pubmed-meshheading:20832114-Diabetes Mellitus, Type 2,
pubmed-meshheading:20832114-Diabetic Neuropathies,
pubmed-meshheading:20832114-Female,
pubmed-meshheading:20832114-Humans,
pubmed-meshheading:20832114-Male,
pubmed-meshheading:20832114-Middle Aged,
pubmed-meshheading:20832114-Neuropeptide Y,
pubmed-meshheading:20832114-Pregnancy,
pubmed-meshheading:20832114-Radioimmunoassay
|
pubmed:year |
2010
|
pubmed:articleTitle |
Plasma neuropeptide Y levels differ in distinct diabetic conditions.
|
pubmed:affiliation |
Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria. aysegul.ilhan@meduniwien.ac.at
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|